Optimising MRI in Multiple Sclerosis Drug Development

Optimal designs for proof-of-concept studies in multiple sclerosis

Read more

This review will summarize important design issues in proof-of-concept studies of RRMS with an emphasis on optimizing neuroimaging outcome measures designed to help speed clinical development of novel drugs and biologics.


Chief Development Officer
Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?